Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Down 22% & right back up +3.7%, hope u guess my name...!
Just reading an article on the patriots on my lunch break :
“FOXBOROUGH, Mass. — The too-old, too-injured, too-slow 40-something quarterback had just reached his 13th career, and eighth consecutive AFC championship game and he seemed eager to cash in on the rarest of labels for his New England Patriots — underdogs.”
Well who knows, but I’m sure there is a few women who would appreciate a little divine intervention right now !
Just talked to my packer @ work, he left earl Fri due to snowstorm—His last pallet packed for shipping had
13 boxes on it...!
OMG ic toc tic toc...
Leprisonnier,,check your Rob Royea retweets on Twitter, notice the poster “Hello”—tic toc tic...
Price alert TD Ameritrade set at .05...
Flashed on phone, not .005 what the hell, all I wanted to do was set my alarm since I can’t fall back to sleep
what the hell...tic toc
Nice Squirrel...I like this article quote (been a long term hold for me)
“, but the key message is "Why run when you can just walk?” To expand on that: Most people love to innovate but hate change. If one wants change to happen, change management and bringing people along for the journey simply takes time, so patience is key!” tic toc tic...
13 Again ? Rob Royea Cyrcadia
Sunday Jan 13
Rob Royea Re-Tweet “about to take a trip for all you digital peeps”
So I turn my iPhone on this am the 13th & behold a Rob Royea tweet alert “above” appears (13th), so i check it out a re-tweet for Eugene Borukhovich (he is traveling to multiple China locations)
Global Head, Digital Health Incubation & Innovation Bayer Corp-
Oct 1, 2017 Eugene Borukhovich is global head of digital health and innovation at Bayer, the German drug maker. (“ Love startups, game changers and the sharing economy” source Linkedin)
So the 1st article I pull up from Eugene is
“Re-imagining Healthcare (from 2013)”
again the 13th
https://medium.com/@healtheugene/re-imagining-healthcare-from-2013-94193b3b83e
Then I click on the bullet point for
Isabella Health & the date Oct4,2013 appears...! Again 13
(Past quote from Eugene “the health IT work being done to understand, aggregate and connect silos of data in a clinical setting – and sees digital health as an integrative superstructure”. What’s that sound like? Cyrcadia Data Services
Rob Royea
NNBW staff
February 11, 2013
“Rob Royea has been named chief executive officer for First Warning Systems, Inc.”
Rob hired to take iTBra ALL the way in the yr “2013” !!!
https://www.nnbusinessview.com/news/rob-royea/
—“Has proven visionary expertise in facilitating market expansion through merger, acquisition, strategic partnership, and corporate branding resulting in sustainable revenue and EBITDA gains.”
https://medicinex.stanford.edu/medx-speakers/rob-royea/
((remember my previous PPS post based on “EBITDA” valuation...PPS .22...!!!)) I can say now my valuation may be Low ?
Could a Bayer buyout be possibly in the works...???
“Our broad product portfolio includes many world-famous brands which have shaped the iconic Bayer brand. With our innovative products*, we help to make life better.”
I have no insider information, but now would be a really good time to own shares of LLBO & not caught with no shares due to trading activity...because something big is coming...tic toc tic
(((This relates to my previous 13 post as well as news on Sunday—Don’t know that a Rob retweet is news but it was something)))
Will we get news this Sunday ??? Who the hell knows, but I do know that LLBO will defy the laws of gravity some day !!!
Remember my previous post about 13. The
13 radio signals...again 13
https://www.yahoo.com/news/mysterious-repeating-radio-signal-detected-231545171.html
Good am & Thank U...tic toc tic
Al Medical Asia Conference
Nov 8-10, Hangzhou, China
“ artificial intelligence (AI) in medicine and health care”.
(Note-One of the speakers is John Mattison assistant medical director chief health information officer of Kaiser Permanent Health, Kaiser is one of the companies Cyrcadia Health is pursuing with the IT bra, I mentioned Kaiser many months ago in my AARP post Virtual Medicine before Cyrcadia made it public knowledge(post-new investor information.)My only point being that the conference speakers are medical people not product Companies & I would certainly think the iT Bra technology would be discussed in the Digital Medicine & Wearable Technology sec5 below ?)
Entry Categories:
1. Decision support and hospital monitoring
2. Medical Imaging and Biomedical Diagnostics
3. Precision Medicine and Drug Discovery
4. Cloud Computing and Data Security
5. Digital Medicine and “”Wearable Technology””
6. Robotic Technology and Virtual Reality
“AI Med Conf: is a unique collaboration between innovative medical and technology entrepreneurs that seeks new ways of thinking about healthcare delivery in the 21st Century. It brings together innovative technology providers, policy makers, executives and leading thinkers to imagine new models of healthcare service delivery, engagement and mobility that puts patients at the centre of the AI healthcare revolution.”
Sally Daub, Board Member and Executive Advisor, Enlitic”
Tic toc ...
(Good article below mentions IFlytech Co. and wearables great need in China, & I wonder who has invested in the iT Bra, OH iFlytech Co. !)
https://www.google.com/amp/s/techwireasia.com/amp/2018/06/chinas-quest-for-better-healthcare-with-ai/
Jim crammer
@JimCrammerWX
New
@JimCramer iTBra could become a household name once it gets a likttle exposure
10:46 AM Oct 10?3,722 people are talking about
iT Bra, very good article:
https://www.silkroad40.com/new-iot-bra-can-detect-early-signs-breast-cancer/
Excellent Article
https://www.medtechintelligence.com/column/high-demand-for-breast-cancer-diagnosis-and-treatment-products-in-asia/
In Asian countries, the peak incidence age for diagnosis of breast cancer is between 45 and 50, which is 10 years younger on average than in the United States and Europe, according to the WHO. And in more than a quarter of the cases, the disease has already progressed to its more dangerous stages by the time it is detected.
Copy only below, update if repost ie:84% or better detection & PhoneApp to AI data bank for analysis sent then to Doc with breast incident location
“New”Investor Information:
Evolving Role Of Thermal Dynamic Analysis &
Is Telemedicine the Future of Care.
Cyrcadia Health
(Lifeline Biotechnologies
LLBO, PPS your guess ?)
Huge mkt for women who want home privacy & life saving ability to do a simple reliable breast examination between annual breast check ups, the iT Bra allows this peace of mind. With the new breast screening guidelines out recommending screening every other year after age 54, the IT Bra will be ideal for those long in between screenings, oh and the new guidelines also don’t recommend the old self examination “by hand”, hell let’s just let the tumor grow into an elephant. What’s left, the iT Bra or a crystal ball, which would u choose ???
https://www.ncbi.nlm.nih.gov/ (The evolving role of the dynamic thermal analysis in the early detection of breast cancer-National Center For Biotechnology Gov: “Cancer development appears to generate its own thermal signatures and the complexity of these signatures may be a reflection of its degree of development.
The limitations of mammography as a screening modality especially in young women with dense breasts necessitated the development of novel and more effective screening strategies with a high sensitivity and specificity. Dynamic thermal analysis of the breast is a safe, non invasive approach that seems to be sensitive for the early detection of breast tumors . The limitations of mammography as a screening modality especially in young women with dense breasts necessitated the development of novel and more effective screening strategies with a high sensitivity and specificity.st cancer.
With increasing evidence that inflammation can enhance tumor growth and is associated with a poor prognosis, this suggestion implies that thermal analysis may have considerable value [30].
The evolving role (Artificial Intelligence)of the dynamic thermal analysis in the early detection of breast cancer”.
M Salhab, W Al Sarakbi, and K Mokbel
It is now recognised that the breast exhibits a circadian rhythm which reflects its physiology. There is increasing evidence that rhythms associated with malignant cells proliferation are largely non-circadian and that a circadian to ultradian shift may be a general correlation to neoplasia.
Cancer development appears to generate its own thermal signatures and the complexity of these signatures may be a reflection of its degree of development.
The “limitations” of mammography as a screening modality especially in young women with “dense breasts”
necessitated the development of novel and more effective screening strategies with a high sensitivity and specificity. Dynamic thermal analysis of the breast is a safe, non invasive approach that seems to be sensitive for the early detection of breast cancer. End
(iT Bra fits right in)
(Gene identification for breast tumor risk testing is NOT going to change that in any way.)
Cont’d from top:
Is Telemedicine the Future of Care?
One such very large medical Co. that is currently being approached by Cyrcadia Health (iT Bra) is-Kaiser Permanente Co. ( mentioned in AARP article below),
Kaiser preaches “Early Diognostic Prevention”...& the iT Bra is something they cannot afford to shrug off.
Virtual Medical Care Huge Future:
Glad to see that Cyrcadia Health will be indirectly involved with Kaiser Permanent
(I brought this up as a target mkt below, prior to Cyrcadia Health 2017-2018 report release, glad to see they are going right
after the Virtual med mkt.).
Let’s just look at what is literally appearing before our eyes to help answer this question
“This is the future of Medicine...”
Telemedicine Revolution (patients/doctors converse anywhere)—Fact, Hospitals Without Patients (virtual care) 2016 mega growth industry had sales of $14 Billion Dollars, growth projection
expected to $36 Billion Dollars by 2020, (2yrs) WOW, project that growth line and
You fall out of your seat (iT Bra I would say is properly named).
Mercy Virtual medical bldg is 6 miles from my home, a mega structure loaded with over
400 doctors, nurse specialist, &
medical technicians (not one hospital bed). All who supported more than 44 hospitals in the Mercy network,
in over 10 Midwest states (had over 750,000 thousand patients just last year.)
(Why? Patient convenience, privacy, more efficient healthcare, saving money & more important life’s).
1)Mercy Virtual 2)Kaiser Permanente 3)Cleveland Clinic 4)Intermountain Health Care, 5)Dignity Health,
6) Avera Health—just names of mega hospital major healthcare providers networks with millions of patients getting in on the game...
AND one hell of a big game it’s going to be.
One strategy these players are aiming for is Primary Preventaive Medicine “Primary Care”, ahhh musical notes
to who else, but our cheer leaders the Insurance Companies, a growing garden of health care medical care
payout savings, and wow are they cheering...!
Go iT Bra
So who do you think Cyrcadia Health is targeting ask your self ?—why the extensive clinical trials when they already have FDA Class ll Clearance, and mktg/sales program in Asia just about to begin 2018, because they want to get it right (their AI Artificial intelligence algorithm, also just recently brought to my attention, the medical community is wanting to see the clinical trial data ASAP when it can be released-this will be huge for Cyrcadia Health)
This iT Bra no pun intended fits right into the “Telemedicine Revolution” and the timing could not be better.
(reducing anxiety, commute time/expense/carbon foot print, giving privacy and saving a life for millions of women connected all over the world, ask yourself would you pay less than $100 to possibly save your life & not be exposed to low level radiation, what would an insurance co pay to save millions of dollars ?
Yes the TeleMedicine evolution is here fellow investors (I currently own 2 Mil shares LLBO.
In case anybody was wondering, I have no connection with the company and do my own research).
My hats off to Cyrcadia and Mercy Virtual for preventing/ reducing early unnecessary deaths,
hospital admissions, emergency dept visits, saving untold millions of dollars.
The price of admission is life...
I guess only time and a life saved will answer the question what if
DETECTED ?
(Cisco Corp was instrumental in helping Circadia Health produce a film about their iT Bra called Detected.)
Previous post # 24768, which u can enter the post num at the top GoTo search box above, has information
on some current investors as well as clinical trial data.
Source:
AARP magazine article Feb/March 2018 “Is Telemedicine the Future of Care ”
& “The Digital Doctor Is In”, explores how telemedicine is transforming healthcare.
Excellent article and anyone that invest in any kind of healthcare should definitely read.
(I know one thing the executives at Cyrcadia Health are).
More Info:
Mercy Virtual & the other Mega health institutions, again discussed in this months AARP
journal (April/May) as well as Cisco (per my prior investigative post below), continue to educate the
public on this explosive growth industry-“Virtual Health Care”.
Cyrcadia Health-get the data and the iT Bra out !!!
This technology has never “NEVER” been tested & had advanced algorithmic data collection
based on the very latest technology that it has today...the sensitivity of the senors & AI source
interpretation of data, surpassed Oxford when they were also running test many years ago.
Sensitivity (detection) for women with other conditions-dense breast tissue is approximately 60% & that is many women, but the
iT Bra has a very large
improvement in final outcome sensitivity (Detected).
American Cancer Society facts
“Radiation Exposure”:
Because mammograms are x-ray tests, they expose the breasts to radiation. The amount of radiation from each mammogram is low, but it can still add up over time.
(Time ???)
A false-negative mammogram looks normal even though breast cancer is present. Overall, screening mammograms do not find about 1 in 5 breast cancers.
(=20%, & I have to wait one more year for another mammogram, not if I have the iT Bra!)
Worldwide over 1.7 Million
women will be diagnosed with breast cancer~2018.(25% of all new cancers in women are breast cancer, it is the fifth most common cause of death from cancer in women.)
Netherlands study:
A recent large scale service screening report from the Netherlands involving almost 175,000 cancers with linked data mammography, pathologic conditions, and breast cancer death outcomes. Stated that Breast cancer mortality increased significantly in both studied cohorts (before and after institution of modern chemotherapy) with increasing tumor size for tumors as small as 10 mm. The major conclusion of the report was that “Diagnosis of breast cancer at an early stage remains vital,”
VITAL
hence metrics involving tumor size, lymph node status, and cancer stage continue to be important indicators of quality performance.
****************
With 20% of cases not detected & tumor SIZE so important & I’m going to wait over two years for “2” mammograms???
iT Bra at least gives me a fighting chance.
I truly believe it would be totally insane for the virtual medical market not to be taking a very close look at this technology “iT Bra” and doing what they can to support it.
iFlytek Corp. Invest in Cyrcadia Asia (Cyrcadia Health-Lifeline biotechnologies
LLBO)
China is pushing domestic and overseas markets to lower the cost of cancer drugs to make them more accessible.
The country’s cancer rates have soared in recent years, caused by people succumbing to the disease due to heavy smoking, pollution and living to an older age, raising concerns about the prevalence of the disease.
Last year, the National Cancer Center reported that there were 4.29 million new cases of the disease every year and 2.81 million deaths.
The five-year cancer survival rate was just 30% in 2015, less than half the US level, prompting the Chinese government to pledge to improve on this by 15 percentage points by 2030.
China’s new medical insurance regulator, The State Medical Insurance Administration, is planning to include more cancer drugs on its list of medicines eligible for reimbursement.
So far, 10 foreign and eight domestic pharmaceutical companies have expressed a willingness to work with the administration to boost availability so more people can benefit from medication, as more drugs are added to the insurance system.
China removed tariffs on all imported cancer drugs from May 1, following a decision by Premier Li Keqiang in April.
Breast cancer is the most common type of cancer in women in China. Data shows that this cancer has increased at a rate of around 3.5% a year from 2000 to 2013, compared with a drop of 0.4% a year over the same period in the US.
Levels are highest in urban areas. In small cities with a population below 500,000, the incidence of breast cancer is 30 per 100,000. For large cities with a population above 1 million, the incidence is 60 per 100,000 women.
iFLYTEK, a global AI giant, has recently invested in breast cancer detection smart bra manufacturer, Cyrcadia Asia (iT Bra -LLBO US stock symbol). In Asia, many women either cannot access healthcare, or are unable to expose their bodies due to social, economic, or religious reasons. For women in many of these countries, discovery of the disease comes too late, and treatment is ineffective.
The iTBra contains two breast patches that detect circadian temperature changes within breast tissue. Anonymised data obtained from the iTBra is communicated directly to the Cyrcadia Health core lab for analysis via PC or smartphone.
Cyrcadia Asia operates under a strategic license and cooperation agreement with US-based Cyrcadia Inc to exclusively manufacture and commercialise the product for markets in Asia.
End
iTBra is a novel breast health screening device and method based on disruptive technology and tissue health science. The system is a non-invasive breast physiology screening system, much more sensitive and much more cost effective than mammography. The platform has applications for both OB/GYN and primary care in-office use, as well as potential use as an over-the-counter (OTC) diagnostic system.
$$$ OTC
Some of the companies operating in healthcare artificial intelligence market space include AiCure, Cyrcadia Health-(LLBO), Google, IBM, and Microsoft. Increasing investments by industry players and growing interest of venture capital firms will spur revenue growth. Healthcare artificial intelligence industry is witnessing growth in startup units in recent years and the trend is anticipated to continue over the forecast period.
Cyrcadia has and will be seeking multiple resources to execute its business plan, including major companies interested in Cyrcadia's technology and its proven early breast cancer detection process.
?https://www.reuters.com/brandfeatures/venture-capital/article?id=14381&pid=3036&pp=undefined ?
?iTBra release finally, this Jan 2019 in Asia Cyrcadia Health Co. LLBO stock (saving women’s lives dense breast tissue )?
Breast cancer #s:
Asia Breast Cancer Screening Market Forecast (Mammography, MRI & Ultrasound) 2017-2022 - Research and Markets
July 11, 2017 04:45 AM Eastern Daylight Time
DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Asia Breast Cancer Screening Market Forecast (Mammography, MRI & Ultrasound)" report to their offering:
“Asia Breast Cancer Screening Market Forecast (Mammography, MRI & Ultrasound)”
Tweet this
Asia breast cancer screening market size is expected to cross over US$ 4 Billion by 2022
China, Japan and Korea are the top most contributors. Increasing breast cancer awareness, government and NGOs support breast cancer screening programs and ageing women population are major driving forces for this market. Key threats for breast cancer market in Asia are societal fear, misconceptions and cultural barriers for Breast Cancer Screening. Other major challenge being faced by almost all Asian countries is non availability of national level screening program; however partial or regional screening programs are available in few of these countries.
China is clear winner in the Asia breast cancer screening market. It controls nearly three fourth of the total screening market due to its large women population. Despite poor awareness about breast cancer screening, government partial screening programs and Global as well as domestic NGOs initiatives is helping China to become leader in the Asian breast cancer screening market.
Mammogram is leading methods for the breast cancer screening in the Asian countries. Other popular available methods are MRI and Ultrasound. China, Japan and Korea are top three countries for breast cancer mammogram screening. Their combined share was over 90 percent in 2016. India, Singapore, Malaysia and Thailand are other market for breast cancer mammogram screening.
All the 7 countries in the report have been studied from 7 viewpoints:
- Asia Breast Cancer Screening Market and Forecast
- Asian Countries Breast Cancer Mammography Screening Population Numbers and Forecast
- Asian Countries Breast Cancer MRI & Ultrasound Screening Population Numbers and Forecast
- Asian Countries Breast Cancer Mammography Screening Market and Forecast
- Asian Countries Breast Cancer MRI Screening Market and Forecast
- Asian Countries Breast Cancer Ultrasound Screening Market and Forecast
- Asian Countries Breast Cancer Screening Market and Forecast
7 Asian Countries Studied in the Report are as Follows:
1. India
2. China
3. Japan
4. Korea
5. Singapore
6. Thailand
7. Malaysia
WHO position paper on mammography screening [pdf 584kb]
Overview
Every year, breast cancer kills more than 500,000 women around the world. In resource-poor settings, a majority of women with breast cancer are diagnosed at an advanced stage of disease; their five-year survival rates are low, ranging from 10-40%. In settings where early detection and basic treatment are available and accessible, the five-year survival rate for early localized breast cancer exceeds 80%.
Breast cancer can be detected early through two strategies: early diagnosis and screening.
* Early diagnosis is based on improved public and professional awareness of signs and symptoms associated with cancer; it entails recognizing possible warning signs of cancer and taking prompt action.
* Screening involves the systematic use of testing, such as mammography, across an asymptomatic population to detect and treat cancer or pre-cancers.
The new WHO position paper examines the balance of benefits and harms in offering mammography screening to women after the age of 40 in a variety of settings.
You are here:
Cyrcadia Health has released pricing on their iTBra home use & upload to AI Cloud-Doctor-Patient analysis. Target of $100-150 total for 12 monthly scan uploads (initially $200-250) With a 1:61 chance of getting invasive breast cancer, Hell I’d buy all the lottery tickets I could with those odds, so don’t u think they’ll sell a few iTBras...my wife sure the hell thinks so...
Asia this “Jan2019 launch”—Family Practitioner, OBGYN, Hospital, etc. The 2nd phase is OTC market mid/late 2019...China 2020, maybe late 2019, same time period for balance of Asia, Australia.
CA is currently working with major Sportswear company to incorporate iTBra tech into sports/athletic Bra
LLBO iTBra cost & launch Date:
?Cyrcadia Health LLBO iTBra Asia launch Jan2019 home self brst exam/upload to AI Cloud analysis to doctor.Target annual cost $100-150 tot for 12 monthly scan uploads 1:61 chance of getting invasive breast can,wom pls use. Get frm OBGYN 2nd phase is OTC mkt FDA approved?
Cyrcadia Health LLBO iTBra Asia launch Jan2019 home self brst exam & upload to AI Cloud analysis Target of $100-150 tot for 12 monthly scan uploads 1:61 chance of getting invasive breast can,wom pls use FamilyPractitionerOBGYN. The 2nd phase is OTC mkt FDA approved
Cyrcadia Health has released pricing on their iTBra home use & upload to AI Cloud-Doctor-Patient analysis. Target of $100-150 total for 12 monthly scan uploads (initially $200-250) With a 1:61 chance of getting invasive breast cancer, Hell I’d buy all the lottery tickets I could with those odds, so don’t u think they’ll sell a few iTBras...my wife sure the hell thinks so...
Asia this “Jan2019 launch”—Family Practitioner, OBGYN, Hospital, etc. The 2nd phase is OTC market mid/late 2019...China 2020, maybe late 2019, same time period for balance of Asia, Australia.
CA is currently working with major Sportswear company to incorporate iTBra tech into sports/athletic Bra
Asia female pop:
((current female population of Asia is 2,550,000,000
BILLION (say what!)
49.6 % of the population is urban, median age is 31—4Mil iTBras no problem))
New investors: A women with the odds of 1:8 getting breast cancer over the course of her life has her hand on her breast looks into a mirror, seeing her reflection there is no hand, but instead she is wearing the iTBra tested
& proven technology with FDA approval & she ask herself my hand for early tumor detection or proven advanced technology for $150 total annual cost which includes 12 screening uploads to Cyrcadia AI cloud data center which transmits analysis back to her & Physician (Ins Cos also if requested), in just minutes ?
So I ask you, how many lottery tickets would u buy with 1:8 odds that’s right MANY, well with over 700 Million
women between 20-60 age don’t u think we may sell some iTBras...!
Expected Asia launch Jan 2019, then world roll out. Backed by worlds largest artificial intelligence
Co-iFlytech Corp., Cisco Corp., & currently in talks with major Health Ins Co’s.
(((If u really need to know more scan this forum many good people have posted “Factual” info.,
and/or read the following post after drinking a pot of coffee!
#27171 PHd cancer researcher perspective Hint: U may be induced to buy more shares!
27131 PPS it’s long, but conclusion pps.22 or more
27094 Co marketing intent, the short “it’s happening”!
27061 Market size & Need, Summary-It’s Huge & Needed
26944 Insurance Ins perspective-Ho Ho Ho Merry Christmas, AARP nailed it!
27037 Number of breast cancer cases & importance of earl detection- Your life may depend on it
26370 iFlytech Corp.-Invest in healthcare through acquisition- Say what ?
25922 (now drink more coffee, lots of it), The technology, Virtual medicine growth, Mkt size, Asia waiting!
Hell just buy some shares sit back & think of green pastures!!!
Launch announcement
exerts:
Reno, NV , Feb. 28, 2018 (GLOBE NEWSWIRE) --
Lifeline Biotechnologies, Inc, (“The Company” ) (OTC PINK: LLBO) Provides Information to the Public and Updates It’s Shareholders.
Jim Holmes, Lifeline’s Cyrcadia Health CEO commented “After over 20 years of product development, testing and validation, over $20 million of investment, 2018 is scheduled and expected to be the first year of sales of our potentially lifesaving product. Our tested and proven technology, from our multiple rounds of clinical trials, has shown early identification of breast tissue abnormalities, many of which could lead to cancers, potentially can save lives and costs.”
Cyrcadia, Inc. – 2017 Year End and 2018 Look Forward Newsletter
by admin | Feb 21, 2018 | News |
“Our priority now is to finalize and implement our marketing plan enabling the ramp up of sales as soon as possible in 2018 upon product delivery.”
“On behalf of the Cyrcadia, Inc. team, we thank you for your support as we bring this life saving technology to market. We will make every effort to ensure timely and profitable delivery of CI’s technology to the “U.S. market”and rest of world outside of the territories covered by CA.”
Sincerely,
Matt Benardis
CEO
Cyrcadia, Inc
Rob Royea Cyrcadia Asia CEO: Jan 2019 launch interview
Oct 31 2018:
Reno, NV May 29, 2018, Cyrcadia Health “B” Warrant Acceleration Option
by admin | May 29, 2018 | News
Based on 2018 Go-To-Market plans, investment infusion is paramount in keeping on track and maintaining our accelerated pace. Our stakeholders have been essential in supporting our march to bring the most advanced Breast Health product to market.
“Principals of these companies have been involved with Cyrcadia Health for a number of years and have a deep understanding of our value proposition to bring significant value to our Go-To-Market launch,” says Matt Benardis, CEO.
May 4, 2018, Reno, NV. Expanded Go-To-Market Team
by admin | May 4, 2018 | News
Cyrcadia, Inc. is pleased to announce the addition of Marly Heidkamp, Chief Operating Officer, R.N., MSEd to the executive team to focus on execution of the Go-to- Market plan. Jim Holmes, CFO, say, “We are pleased to have an operations executive join our team who possesses medical product management experience as well. We are confident her leadership will bring added perspective to a product targeted for the female population.” Matt Benardis, CEO, added “We have already seen results from her leadership of the recent kick-off meeting with the comprehensive Go-To- Market team and her engagement of each department regarding oversight, organization and accountability.”
The human element of IoE changing the way breast cancer is detected
TechNovember 03, 2015 08:47
By Vatsun Thirapatarapong
10,540 Viewed
exerts-
Cisco and Cyrcadia Health are involved in the development of an “ iTBra”...
, iTBra will provide thousands of women with early warnings of cancer formation, enabling doctors to implement treatment plans to save lives in time.
Cisco has been following Cyrcadia Health’s efforts closely as their work is a major example of how innovation, made possible by the Internet of Everything, can change and ultimately save lives...
Cisco is chronicling the story of the iTBra by funding a documentary scheduled for release later this year...
More important, is the story of how the connected health industry – poised to be a billion market by 2018 – could change everything we know about medicine.
iTBra is only one example of the Internet of Everything at work in the healthcare industry. In the next three to five years, the number of health-related connected devices will soar. The globally connected health market will grow at an annual growth rate of 33 percent by 2019.
China's AI leader iFLYTEK invests in breast cancer detection wearable Cyrcadia Asia
2018-07-16 09:00:
exerts-
The Pre-A funding enables Cyrcadia to complete product development and launch into Hong Kong and other Asian markets in late 2018...
Commenting on the deal, Tao Xiaodong iFlytech Med Dir.,said: "We are excited to play a leading role in the development and launch of Cyrcadia's technology. iFlytek is already harnessing the power of AI in healthcare, but Cyrcadia's technology,...
As Cyrcadia's user base grows, it has the potential to be the world's largest data base of breast health and breast cancer incidence...
Asia Co-Investors Club
(Past Events)
exert-
Rob Royea, CEO of Cyrcadia Asia, shared his journey with us on 8th October, from the initial idea to the launch of a path-breaking device that has the potential to save millions of lives.
September 21, 2018
Ameing for Asia
exert-
High Demand for Breast Cancer Diagnosis and Treatment Products in Asia
iTBra, through its Hong Kong subsidiary. The company plans a further expansion into China, Indonesia, Malaysia, the Philippines, Singapore and Thailand before the end of the year...
Swiss Association & Swiss Chamber of Commerce
Joint Monthly Luncheon,
Oct8 2018
"Detected"
Guest Speaker: Rob Royea CEO, Cyrcadia Asia, Ltd.
Imagine a world where AI detects breast cancer through a bra. That world is just a “few”months away.
Mammograms can miss the presence of cancer in up to 50% of the scans, especially for women with dense breast tissue, which is the case for more than 60% of Asian women. The revolutionary iTbra, worn for just 2 hours once a month, uses AI to interpret metabolic changes and increases chances of early cancer detection to more than 85%.
Join us to learn about Rob Royea's journey from the initial idea to the launch of a path-breaking device that has the potential to save millions of lives.
About the guest speaker: Rob Royea currently acts as the CEO of Cyrcadia Asia. Previously, Mr. Royea has led global efforts of both public and private venture backed technologies, with demonstrated successes in the healthcare and retail markets, from start-up to over $550M in sales.
Most recently, Mr. Royea structured the sale of Qi Imaging, Inc. (Ziosoft US/Japan) to Dr. Patrick Soon-Shiong's Nantworks to enable a centralized patient data domain containing imaging and genomic data targeted at cardiovascular and cancer research. Mr. Royea was awarded the Top 40 Healthcare Transformer honor by MM&M Magazine in 2016, and his leadership helped Cyrcadia to be awarded the Gold Edison Award for Top Wearable Device in Healthcare in 2016.
Through Cyrcadia Asia, Ltd, Mr. Royea is now introducing a wearable early breast cancer detection technology designed to provide peace of mind for women when the iTBra is worn as an intelligent monthly breast screening
solution. The iTBra will automatically alert the women's physician and insurance provider to an early cancer indication and promises to improve dense tissue accuracy and to reduce unnecessary breast surgeries.
Date: 8 Oct 2018 (Monday)
Time: 12:00 – 14:00 (Registration and pre luncheon cocktails starts at 12:00)
Venue: Harcourt Suite, The Hong Kong Club, 1 Jackson Road, Central
Function Room reserved by Mr Guido Furrer
*Shoes with rubber white soles, sport shoes and jeans are not acceptable
Please visit here for the dress code of Hong Kong Club.
All the members and their guests should dress accordingly.
Late registrations, walk-ins will be accommodated on a best effort basis?Price: HK$430 per person for SwissCham & SAHK Member? HK$530 per person for Non-member, late registrations & walk-in guest?Registration: Please send your RSVP to admin@swisschamhk.org by 2 Oct 2018 (Tue). The cheque should be made payable to "Swiss Association of Hong Kong" and mail it to GPO Box 9232, Central, Hong Kong. If you prefer to do the payment by bank transfer, please let us know.
LLBO MrWowza
(Wowza you still In LLBO, great DD post you did in 2015, we’ll launch this Jan 2019)
(Yes the 5 wearables, hey check this out post#114495 old DD post, doesn’t post here any more at least not with the old name...go to 4search.com, type in iTBra & go to article #63 ,,talk about hrs of work this guy has me crushed unfortunately he/she won’t respond to me, erases my post ASAP I saved an original copy just in case it mysteriously disappears... can’t find it I anymore, you can try though ???)
IHUB: #114595
Why LLBO is next big thing in bio sector? please read full DD:
Post#114595
I am sharing my honest opinion based on facts!!! Starting my research from "ITBRA" because this name and product info already spread like a wild fire all over the world but not many people knows who invented and holds all owner rights. That makes LLBO like hiding "GEM" trading 0.0022!! LLBO doesn't release news so often but people don't realize there are many new articles, posts on FB, Twitter and many other social medias almost everyday about Itbra.
What's ITBRA?
A new technology that could revolutionize breast cancer screening. Rather than a mammogram or ultrasound, this system can be used at home, with potentially life-saving information transmitted through a smartphone.
The technology could help thousands of women and doctors screen for breast cancer in a new way. It's called the iTBra.
Itbra named Ten top health tech innovations
Read the article: http://jessicafurseth.com/2015/09/10/ten-top-health-tech-innovations/
THE FACTS:
There are two agreed upon facts about breast cancer. First, there is no documented way to prevent breast cancer. Secondly, early cancer detection and treatment greatly improves survival rates, in fact 90%+ survive if cancer is found in its earliest development stages.
See the videos what Itbra can do:
https://youtu.be/dmlvznuMeD4
https://youtu.be/QIKqi7NuJ_c
http://cyrcadiahealth.com/abc-7-news-video/
http://abc7news.com/health/high-tech-bra-helps-detect-breast-cancer/496449/
http://abc7.com/health/high-tech-bra-helps-detect-breast-cancer-faster/506633/
ITBRA could be house hold brand and every women's must have list because every 19 seconds, a woman is diagnosed with breast cancer!!!
Facts globally:
There were an estimated 14.1 million cancer cases around the world in 2012, of these 7.4 million cases were in men and 6.7 million in women. This number is expected to increase to 24 million by 2035.
http://www.wcrf.org/int/cancer-facts-figures/worldwide-data
Facts USA:
There will be an estimated 1,658,370 new cancer cases diagnosed and 589,430 cancer deaths in the US
http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2015/index
I will post tons of articles end of my DD and please read them carefully!
ITBRA supported by big names: ITBRA is Flextronics (hardware) Salesforce (software) Cisco (network)
The iTrba manufactured by Flextronics
https://en.wikipedia.org/wiki/Flextronics
[/img]
Flex CEO interviewed:
“Wearable would be the next big thing for us,” Flex chief executive Mike McNamara said Thursday at the Converge technology conference, co-hosted by The Wall Street Journal and founders in Hong Kong. “We are working on glasses, shoes.… We probably do more fitness and wearable devices than any other firm in the world.” Flex has an incubator to help companies take wearable devices to the market, he added.
Read full article: http://blogs.wsj.com/digits/2015/07/30/contract-manufacturer-flex-plans-southeast-asia-push/
Itbra article:
The product looks like a sports bra and will eventually hold a grid-like mesh of sensors, manufactured by Flextronics, inside the fabric
Read full article:
https://gigaom.com/2015/02/10/heres-a-cancer-detecting-bra-thats-better-than-a-mammogram/
http://blogs.wsj.com/digits/2015/07/30/contract-manufacturer-flex-plans-southeast-asia-push
The iTbra is getting a boost via a documentary film backed by Cisco, which will be shown end of this year or early next year!!! Cisco is getting involved because it hopes to build a big business helping old-line companies understand how to bring technology into their day-to-day operations.
http://www.cisco.com/
http://blogs.cisco.com/news/the-internet-of-everything-is-saving-lives-predicting-cancer-with-a-connected-bra
http://blogs.cisco.com/healthcare/using-health-it-to-detect-breast-cancer
Internet of Everything Targets Breast Cancer in “Detected” Documentary
http://blogs.cisco.com/news/internet-of-everything-targets-breast-cancer-in-detected-documentary#more-162736
Watch iTbra movie trail:
https://youtu.be/SIT_jt1k9fc
Cisco's Vice President of the Internet of Everything Practice, Joseph Bradley, describes how the Internet of Everything will make a positive impact in the healthcare industry, starting with a connected bra that can detect breast cancer
Watch video:
https://youtu.be/pA1JOtXNbY8
Cisco has been building huge buzz all over the world with social media, lately have been seeing those twits almost every day. Can't put all links will need few pages.
For example:
https://twitter.com/CiscoIoE/status/656236131290345476
Cisco UK:
https://twitter.com/CiscoUKI/status/657548133140942848
Cisco Canada:
https://twitter.com/CiscoCanada/status/657248803473465344
Cisco India:
https://www.facebook.com/Cisco.in?fref=ts
More info from Detected official site:
http://detectedmovie.com/
A lot's info can be seen Detected FB:
https://www.facebook.com/detectedmovie
Okay, guys let's get in to main DD about LLBO
LLBO website: http://www.lbti.com/
About Lifeline Biotechnologies:
Lifeline Biotechnologies, Inc. (OTC Market: LLBO) founded in 1994 is based in Reno, NV. LLBO has invested over $10M in a device and process for early detection of breast tissue abnormalities some of which are cancerous or pre-cancer. Three “Proof of Concept” clinical trials of over 500 women have been completed and three patents (one hardware, two software) have been awarded.
LLBO is invented and already invested 10M in to ITBRA and owns the patents therefore the technology!! That mean is if a big pharms want this technology they have to deal with LLBO!! /buy out or revenue sharing/
LLBO Share Structure:
SS looks big but amazingly they haven't added a single share to the float since 2009!! That mean is float mostly held by strong hands and you will see how it moves on light volume!! Remember VFIN comes once a while but he doesn't do any damage!! he sells few and moves!!! so no panic!!! This stock reminds me EPGL very much!!
Shares Outstanding 3,026,680,967 a/o Sep 30, 2014
Float 650,000,000 a/o Jun 30, 2009
Authorized Shares 4,950,000,000 a/o Sep 30, 2014
Par Value 0.001
How iTbra started:
In early development, Chronodynamics had completed two rounds of testing involving approximately 350 women. The first proof-of-concept trials were conducted at The Ohio State University’s Oncology Hospital. The next round of study was conducted at Green Memorial Hospital, Dayton, Ohio. The Green Memorial Principal Investigator was Dr. Ronald Fletcher. Dr. Fletcher was head of oncology at Green Memorial and former head of the Health Department for the State of Ohio. The last round of patient testing with 188 subjects was conducted at Clem Plam Breast Clinic, La Plata, Argentina under the direction of Dr. Marten Laguens, a noted Argentinian Pathologist at the University of La Plata. The System proved to have similar accuracy to mammography across all tissue types. In addition, the system found tissue abnormalities, where the biopsy proved the state of cancer, in patients with smaller tumors than normally visible with mammography, and with those difficult to image or "dense breasted" populations that mammography was simply unable to ascertain.
Management then engaged groups of aerospace and computer engineers from Nanyang Technological University (NTU) and Ngee Ann Polytechnic University (NAP) respectively, both in Singapore, to review the patient data and validate the results. The request made of these pattern recognition and algorithm experts was to improve and expand the neural nets and their capabilities to identify cancers. Following NTU’s validation, the principals of Lifeline and the engineers at NTU and NAP filed for three US software patents. The patents were granted in 2012. The patents were assigned by the five inventors to Lifeline Biotechnologies.
Upon validation of the technology, Lifeline formed an affiliate, First Warning Systems, Inc. (now Cyrcadia Health) in 2008 to obtain a better valuation of the technology and reduce the cost of capital and dilution. A license, in exchange for shares and a revenue royalty of FWS, was entered into conveying rights for further development of the technology and the worldwide marketing rights.
Must see Ibtra saved human life, very emotional video:
Published on Sep 28, 2012
First Warning Systems, Inc. celebrates Breast Cancer Awareness Month with the release of a testimonial account of Nedra Lindsay's 19 year breast cancer survival.
Watch video:
https://youtu.be/3iOiOSwPdgY
Now we know why LLBO is not putting news very often because Cyrcadia Health is the LLBO!!!! Very smart move that way clinical trail costs coming from outside sources and no dilution needs.
Proof is LLBO has very small debt $360k, no toxic debt!!! LLBO owns Cyrcadia Health's 40% that mean is LLBO will have royalty from future revenue of Cyrcadia!! How much revenue? We will get there!!
Fun part starts about Cyrcadia Health
Website: http://cyrcadiahealth.com/ http://detectedmovie.com/
About company video presentation: https://youtu.be/Gs8VnBrQr4U
Follow Twitter and FB they put posts almost everyday, easy track Itbra trails: https://twitter.com/CyrcadiaHealth https://www.facebook.com/cyrcadia
About Cyrcadia, Inc.
Cyrcadia, Inc. (doing business as Cyrcadia Health), founded as First Warning Systems in 2008, is based in Reno, Nev. The company’s product line is a wearable device and software service that detects breast tissue abnormalities leading to health risk assessment and management including early breast cancer identification. Three clinical trials with over 500 participants have achieved proof of concept and equal to and superior outcomes when compared to other diagnostic protocols. Cyrcadia is undergoing a final, limited clinical trial and a 510k device classification to validate the fourth generation of the product. Cyrcadia technology is exclusively licensed for development, manufacturing and marketing worldwide from Lifeline Biotechnologies, Inc. (OTC: LLBO) The company is preparing to apply for a Euro CE Mark to market in the European Union and Asia Pacific markets, with FDA applications following for the US market.
Cyrcadia press releases reminds who is real boss /LLBO/ but people don't read the end, from now we will be reading kkkkk
Example: http://cyrcadiahealth.com/cyrcadia-inc-announces-clinicaltrials-gov-listing-for-its-entry-into-clinical-trials-for-wearable-breast-cancer-detection-device/
What's going on with IBTRA right now???
July 07, 2015 clinical trails officially started:
Cyrcadia, Inc. (“Company”) announces it is entering into a clinical trial for its wearable breast cancer early detection device and is enrolling the first clinical trial participants at El Camino Hospital, in Mountain View, California. Utilizing its previous FDA cleared device as a predicate, Cyrcadia Health™ (a division of Cyrcadia, Inc.) is combining the Company’s fourth generation, wearable device technology, made by Flextronics, and the SalesForce database software, to track the clinical results
Read full PR:
http://cyrcadiahealth.com/cyrcadia-inc-enters-clinical-trials-for-wearable-breast-cancer-detection-device/
Cyrcadia, Inc. Announces ClinicalTrials.gov Listing for Its Entry into Clinical Trials for Wearable Breast Cancer Detection Device
Reno, Nev. Aug. 11, 2015 — Cyrcadia, Inc. (“Company”) announces its clinical trial listing on ClinicalTrials.gov for its wearable breast cancer early detection device at El Camino Hospital, in Mountain View, California and upcoming additional clinical study sites. ClinicalTrials.gov is a registry of clinical trials. It is run by the United States National Library of Medicine (NLM) at the National Institutes of Health, and is the largest clinical trials database, currently holding registrations from over 130,000 trials from more than 170 countries in the world.
Read full PR: http://cyrcadiahealth.com/cyrcadia-inc-announces-clinicaltrials-gov-listing-for-its-entry-into-clinical-trials-for-wearable-breast-cancer-detection-device/
Clinical Trial progress:
In Progress - To Be Completed
** Funding for Clinical Trial
** Vendor delivery of testing materials
Completed for Clinical Trial
** Protocol for testing accepted
** Internal Review Board (IRB) approved
** Contract with hospital executed
Prospective Partner
** Stanford University's Canary Research
Research in blood genomics
iTbra is enrolling the first clinical trial participants at El Camino Hospital, El Camino Hospital Breast Health Center does 12000 mammograms a year . That's 1000 per month. ITBRA has to be worn 24 hours.
https://www.elcaminohospital.org/services/womens-health/specialty-programs/breast-health
Itbra clinical trails are going with great success:
4:02 PM - 15 Oct 2015 Twit from EI Camino Hospital:
El Camino Hospital’s Dr. Katherine Sutherland can’t help but share her excitement for iTBra and its potential impact on the healthcare industry.
See twit:
https://twitter.com/CyrcadiaHealth/status/654794556169281537
Cyrcadia posted on Facebook that 500 patients have completed trials and counting.
https://m.facebook.com/cyrcadia
iTbrea trails got funding resource :
Reno, Nev. (PRWEB) September 22, 2015
Cyrcadia Health and the Canary Foundation announced their intention to enter into collaborative research on improved early cancer detection screening through the use of Cyrcadia’s wearable devices. Through funding support from the Canary Foundation, Cyrcadia has established a multi-site trial, beginning at a leading Bay Area cancer hospital with near term expansion to the Stefanie Spielman Comprehensive Breast Foundation at The Ohio State University. This research will involve a 173 patient study focused on early breast cancer health screening
Read full PR: http://www.prweb.com/releases/2015/09/prweb12974574.htm
About Canary Foundation
Canary Foundation is a non-profit organization dedicated to the goal of identifying cancer early through a simple blood test, and then isolating it with imaging. Canary Foundation is based in Palo Alto, California and was founded by Don Listwin in 2004. The program areas of the foundation are early detection for ovarian, prostate, breast, lung, and pancreatic cancer.
For more information, please visit http://www.canaryfoundation.org.
Hint Cisco funding through Canary Foundation imo!!!
Don Listwin
Founder and Chairman, Canary Foundation
Don Listwin is a 30-year veteran of the technology industry. Prior to founding the Canary Foundation, Don was CEO of Sana Security, Openwave, and had been the #2 executive at Cisco Systems
What's going to happen with Itbra next???
- iTbra clinical trail should finish end of December of 2015 if there is any delay recording on the government's website
Estimated Enrollment: 173
Study Start Date: June 2015
Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)
https://clinicaltrials.gov/ct2/show/NCT02511301
- Documentary Movie: Detected coming Funded by Cisco will be released sometime end of this year or early next year!! This will bring huge awareness from!!! LLBO stock price should move big time Imo
Jeremy Newberger says:Detected is their next BIG documentary
https://twitter.com/jeremynewberger/status/633276967043923968
Movie trail watch: https://youtu.be/SIT_jt1k9fc
-Market entry, initially outside the US, is estimated to begin by end of 2015 or early 2016.
iTBra commercially available by the end of 2015.
Read:
http://www.justmeans.com/blogs/wearable-sensors-offer-new-hope-for-early-breast-cancer-detection
http://www.justmeans.com/blogs/wearable-sensors-offer-new-hope-for-early-breast-cancer-detection
https://www.facebook.com/Cisco?fref=nf
"Cyrcadia has high hopes for an Asian launch late in 2015 and in the US and Europe shortly thereafter."
http://www.mmm-online.com/features/med-tech-marketing-wearables-and-beyond/article/415874/
- As soon as clinical trail done next 510(k) submission to the FDA and approval takes min 120 days or more!! . However, there can be no assurance that the FDA will approve the Company’s submission. There is a possibility that the FDA could reject the technology and the claims concerning the capabilities of the iTBra™.
-If a 510(k) is approved, commercialization of the the iTBra™ will start, I am willing to wait that day with free shares!!
- Market entry in the US is expected in middle of 2016 (wild case)
Rob Royea, CEO of Cyrcadia Health, says that by 2016 he aims to have FDA approval for the iTbra in the U.S. so doctors can offer it to patients in place of a mammogram. Eventually, consumers would be able to buy the product over the counter and use it in place of monthly self-exams.
Estimate revenue
I don't really know what will be the revenue but sure millions of women even men will be using this product all over the world. I am thinking LLBO will have some buy out offers from big pharmas imo. LLBO will be sharing revenue with Cyrcadia and I don't know what will be royalty or %. But based on what I have seeing and reading Itbra can produce a billion dollar revenue if things go smooth in the future, ( just my dream)
For example:
Fitbit Inc. (FIT) is very similar company with market cap $7,9 billion. Fitbit Inc. manufactures and provides wearable fitness-tracking devices worldwide. The company makes both wrist bands and clippable devices that monitor a user?s fitness activity by tracking the calories burned or distance covered
IBM bought Watson's Eyes $1 billion. Read https://wtvox.com/tech-news/ibm-buys-merge-healthcare-to-upgrade-watson-eyes/?utm_source=dlvr.it&utm_medium=twitter
LLBO could be billion dollar company in the future that makes me very happy investor of LLBO!! Big company like Cisco supporting is makes me more happy!
Ibtra is spreading all over world. Read some articles:
http://www.mtv.com/news/2351036/23-electronic-bras/
http://www.northernvatimes.com/news/iloudoun-the-internet-of-everything-connects-the-county
http://indonesia.shafaqna.com/ID/ID/1723791
http://blogs.cisco.com/news/how-the-internet-of-everything-is-changing-lives
https://twitter.com/Cisco/status/648945843043700737
http://www.huffingtonpost.com/barbara-dehn/why-your-next-bra-could-s_1_b_8158344.html
http://healthleadersmedia.com/content/MAR-320474/4-Ways-Wearables-May-Aid-Patient-Experience-Outcomes
http://www.networkworld.com/article/2925783/cisco-subnet/ciscos-ioe-keeps-abreast-of-cancer.html
https://www.facebook.com/events/343279725867394/
Advertise Here
Don't Miss This Hot Stock
Top Stock To Watch
Wowzastock's members board:
http://investorshub.advfn.com/boards/board.aspx?board_id=20042
My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.o
Well well well, let’s see what Leon Wang: Princeton University Phd researching cancer has to say about the iTBra-
“Skin patches are noninvasive, discrete, and potentially inexpensive enough that I could actually see use by common people on an ordinary basis. Specifically for Cyrcadia and iTBra™, the potential market is huge. There are over 700 million women worldwide between the ages of 20 and 70. In the United States alone, 38 million mammograms are preformed each year. Furthermore, the unacceptably high false positive rate of mammograms leads to an associated cost of over 4 billion dollars in unnecessary treatments annually in the US. If marketed correctly, iTBra™ is not only just a mammogram alternative, it could dominate the entire market
The Bottom Line
Cyrcadia sits on a very mature and proven technology that presents a solution to a “huge” market in which there is no current gold standard. This situation is unique in the startup field and I am very optimistic regarding the future success of iTBra™ and Cyrcadia.”
Tic toc tic...
PPS .22 ??? Or should I recalculate...let’s say on the upside
Full article link:
https://medium.com/startupreview/the-future-of-cancer-diagnostics-vol-3-e3188fefee41
OK ...Cyrcadia Data Services satellite towers should be smokin before to long...
trade them shares, but don’t get caught empty handed...tic toc
Good article
Like I said
“The company noted that if many women use this technology, it could deliver more accurate results for future users.”
-The worlds largest data bank
-Also, the Jan launch was always going to be a Physicians clinical program...for some of our posters that apparently are confused.
tic toc
Short term traders
Day traders won’t kick until news
Long term speculative holders 85-87% SO
Officers 11%
When u do enough reading on this technology, this article really has nothing new to say, doctors are always skeptical of new medical devices. Thc key is Data Sets... the whole purpose of Cyrcadia Data Services, it’s called Artificial Intelligence for a reason.
(The simple algorithms we used in developing electronic smart devices for heat pump defrost cycles used/learned by Time” - temperature variations of the AC coils, primitive vs what’s used now.)
Also, Physicians clinical patients & 3rd quarter commercial market availability were previously released information !
Good update though.
Good article...what else can be said, but tic toc tic
Good point, credibility will lead to far more selling avenues than unsubstantiated hype...
I just love reading this, so I posted again!!!....”Increasing number of users”.
Cyrcadia Gets Iflytek Backing to Take Breast Cancer Detection Patches to Market
LIAO SHUMIN
DATE : JUL 18 2018/SOURCE : YICAI
Cyrcadia Gets Iflytek Backing to Take Breast Cancer Detection Patches to Market
(Yicai Global) July 17 -- Cyrcadia Asia, a startup developing smart breast cancer detection devices, has bagged CNY25 million (USD3.8 million) in pre-A funding led by Chinese tech giant Iflytek.
The money will help the company launch in Hong Kong and other Asian markets this year, and provide a foundation for its A-round this quarter, online news site The Paper reported. The firm penned license deals with United States-based Cyrcadia Health to produce and distribute the devices -- patches worn by women for two hours a month that let them monitor the health of their breasts via a mobile application.
Iflytek is the biggest artificial intelligence firm listed in China, and began its foray into healthcare in 2016. Dr. Tao Xiaodong, an expert with medical imaging and computer-aided diagnosis experience at Philips Healthcare and GE Healthcare, founded the department and is set to become a director at Cyrcadia Asia.
The patches detect cancer by observing metabolic changes, Tao said. This makes up for shortcoming in current imaging technologies and human interpretation, and provides a convenient way for women to monitor their health. The increasing number of users could make the service the largest breast health incidence database, and provide information for research into cancer preventions and treatments, he added.
Iflytek took quickly to the healthcare sector, and in November 2017 its AI robot Xiaoyi passed the national medical exam, the test required to qualify as a doctor in China. The bot scored 456 points, 96 more than the pass mark. The company now runs AI services at more than 50 hospitals in its home province an Anhui, helping doctors to diagnose and treat diseases and interpret medical images.
CH has made it quite clear that with or without FDA over the counter approval, they would fall back on the 510k previous approval...and yes we have not had any updates since that info was released last year.
With all that said I believe Anyone that has reviewed an in depth amount of CH CA data (DD), along with the just hired Physicians Liaison would have a pretty hard time explaining why this product is Not going to market. Many have been found guilty in a court of law with less information !
Either Pro or Con on this stock, I’d highly suggest you own “some” shares.
The drums beat louder...”Physicians Liaison”...Captain one might conclude there will be untold numbers of physicians needing iTBra information as our US launch is imminent, yes you are quite right Spock, we must obtain a Physicians Liaison...tic toc tic tic toc tic toc tic toc ~~~€Launch>
Squirrel excellent excellent find, this I believe is bigger than all of us might think !
My dads & I BDay as well, hey what the hell else do we have to do right now.
(I really like the data satellite tower in Ireland for the Cyrcadia Data Services Co., big son of a gun, right off of the Main Street, earth google focuses it in pretty good-prev post...)
Tic toc tic
Squirrel, I know strange the 13th, but just to break my point of always trying to use facts for hard data or assumptions, just a feeling News may break by the 13th that’s it...!!!
Dam this is tite...
Breast cancer screening: a growing world market12.07.2017
A short view on different markets
~250,000,0000 MILLION Breast Screenings Worldwide ...Say What???
“Breast cancer is the most common cancer in women worldwide, and the number of women affected continues to increase.1 There is thus a large need for early detection options.
China is therefore one of the largest markets for breast cancer screenings, along with the United States, Brazil, Japan, and Germany.” Etc etc.
https://www.healthcare.siemens.nl/mammography/news/breast-cancer-screening-growing-worldwide.html
And to think I only used a fraction of that market for valuation & there’s only one way in to the show...tic tic tic toc...
Welcome PPS ~.22—New investors: A women with the odds of 1:8 getting breast cancer over the course of her life has her hand on her breast & looks into a mirror, seeing her reflection there is no hand, but instead she is wearing the iTBra tested
& proven technology with FDA approval & she ask herself my hand for early tumor detection or proven advanced technology for $150 total annual cost which includes 12 screening uploads to Cyrcadia AI cloud data center which transmits analysis back to her & Physician (Ins Cos also if requested), in just minutes ?
So I ask you, how many lottery tickets would u buy with 1:8 odds that’s right MANY, well with over 700 Million
women between 20-60 age don’t u think we may sell some iTBras...!
Expected Asia launch Jan 2019, then world roll out. Backed by worlds largest artificial intelligence
Co-iFlytech Corp., Cisco Corp., & currently in talks with major Health Ins Co’s.
(((If u really need to know more scan this forum many good people have posted “Factual” info.,
and/or read the following POST after drinking a pot of coffee!)))
Previous Informative Post to read: (just enter in search box above GO)...
#27171 PHd cancer researcher perspective Hint: U may be induced to buy more shares!
27131 PPS it’s long,but conclusion: pps.22 or more
27094 Co marketing intent: the short “it’s happening”!
27061 Market size & Need: Summary-It’s Huge & Needed
26944 Insurance Co perspective: Ho Ho Ho Merry Christmas, AARP nailed it! $$$
27037 Number of breast cancer cases & importance of earl detection: Your life may depend on it
26370 iFlytech Corp.-Invest in healthcare through acquisition: Say what ?
25922 (now drink more coffee, lots of it), The technology, Virtual medicine growth, Mkt size, Asia/World
waiting. Other info.
Hell just buy some shares sit back & think of green grass & high tides!!!
Jim Holmes, Lifeline’sCyrcadia Health CEO commented “After over 20 years of product development, testing and validation, over $20 million of investment, 2018 is scheduled and expected to be the first year of sales of our potentially lifesaving product. Our tested and proven technology, from our multiple rounds of clinical trials, has shown early identification of breast tissue abnormalities, many of which could lead to cancers, potentially can save lives and costs. We/Cyrcadia prepared an analysis of cost savings for a presentation to a World-Wide Major Insurance Company. The medical cost comparison was identifying breast tissue abnormalities and breast cancers at stage 1-3, vs the abnormality progressing to stage 4 or 5 cancer. The cost savings was estimated at over $300,000 per patient. Applying this projected and estimated cost savings to this large insurance, was in the hundreds of millions of dollars annually. (PPS anybody’s guess ?).
Advertise Here
Agree, Oh heck ya right on the money (like someone said in the past the “5 yr chart” is a tornado waiting to grow to an F5). Anticipation has been building up & the spring may just snap with a crack heard around the world.
Oh so right...but, just a hunch nothing more ! When u least expect is most correct.
And it will...13